ClinTec International Celebrates Further Global Expansion
News Nov 06, 2015
ClinTec International celebrated its exceptional year of international growth with Glasgow’s Lord Provost, guests, Country Managers and Directors from over 40 countries, at the ClinTec International Global Conference held in Glasgow last week.
Attended by ClinTec International staff and The Right Honourable Lord Provost of Glasgow, Sadie Docherty, the 4 day event celebrated Excellence in Clinical Research Long Service Awards.
ClinTec International is a success story for British business and has recently been recognized as the “UK’s Best Full Service Clinical Research Organization” at the Healthcare & Pharmaceuticals Awards 2015, organized by Global Health & Pharma. This sits alongside the previously received Queens Award for Enterprise and the 2015 Business Woman of the Year at the Glasgow Business Awards. Commenting on ClinTec International’s growth, the Lord Provost said “ClinTec International has had an exceptional year of growth and they are a great asset to the United Kingdom business sector. These awards show the diversity and quality of the team, which has grown together to develop the global business ClinTec International is today.”
ClinTec International is dedicated to nurturing its employees giving them the opportunity to express their talents and capabilities. Building strong teams and promoting group work, along with open minded, individual thinking was always one of the priorities for ClinTec International. The company fosters an open communication culture at all levels without any discriminations, giving the opportunity for everyone to express their opinion.
Bobby Bal, Chief Business Officer said, “This has been an amazing year for us as ClinTec International has expanded its operations into over 50 countries. ClinTec International now has new entities in Japan, Canada, South Korea, New Zealand and Hong Kong. This success lies with our people and their amazing dedication. At ClinTec International we are committed to developing our employees and we are convinced that our employees are our greatest asset. ClinTec International employees work in several international project teams and contribute towards delivering excellence to our clients, who include 7 of the top 10 pharmaceutical and leading biotech companies.”
Founded in 1997 by the Entrepreneur Dr Rabinder Buttar, ClinTec International now operates in over 50 countries. This exceptional growth is continuing as the company is on track to deliver its 25% revenue growth target for this year.
Dr Rabinder Buttar said, “Our people are our greatest asset as we continue to deliver quality global clinical solutions in our fast, flexible and focused way. With our clients, we continue to align ourselves with their needs to deliver exceptional outcomes, which is due to the strength of our team as they innovate and build. Our Global Management Conference is a celebration of what we have achieved, our cultural values and a reminder of what has made us successful. Keeping this balanced view will continue to guide us as ClinTec International continues to deliver fantastic results and sustained organic growth.”
A key step in ClinTec International’s recent African expansion has been the opening of the new office in Johannesburg. This strategic development is allowing ClinTec International to offer enhanced personalized service delivery across Africa. Presentation of the Corporate Achievement Award, won by ClinTec International at the recent African Achievement Awards for its efforts in helping to develop business and achieve growth within Africa was performed at the ClinTec International Global Conference.
Beltus Etchu, Chair of African Forum Scotland, said, “This is a most exciting and opportune time for dynamic companies to be active in the African continent. ClinTec International has demonstrated both the insight and foresight to prepare themselves to capture this window of opportunity. They have made marvellous strides in pursuing their ethical and totally professional approach to growing their clinical research business in South Africa, Malawi and now into Kenya. We look forward in the coming years, to assisting ClinTec International further grow into Central and Western Sub-Saharan Africa.”
ClinTec International is committed to providing flexible, innovative, agile solutions promoting diversity and gender equality. Their highly trained and experienced local team based in their newly equipped Good Clinical Practice compliant offices in Johannesburg, South Africa are able to conduct fully outsourced studies and offer customized solutions to all their customer’s needs.
Veronica Warren, Director for the Sub-Saharan Region said, “We have an excellent inclusive way of working, championing equal opportunities across our global reach. Behind the African development is a strong and diverse team focused on delivering customized solutions for all of our customers. Our team in South Africa continues to grow as we have expanded existing key client relationships and developed new clinical outsourcing partnerships with prominent Pharmaceutical and Biotechnology sponsors. Recently, we have also commenced clinical studies with research professionals in Kenya, expanding our operational reach even further into Sub-Saharan Africa.”
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
2nd International Conference and Exhibition on Nanomedicine and Drug Delivery
May 21 - May 23, 2018
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018